| 5.83 Data as of May 17 |  -0.03 / -0.51%Today’s Change | 4.35 Today|||52-Week Range 7.67 | -0.34% Year-to-Date |
| Previous close | 5.86 |
| Today’s open | 5.85 |
| Day’s range | 5.75 - 5.90 |
| Volume | 217,992 |
| Average volume (3 months) | 676,165 |
| Market cap | $323.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +30.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 11.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| XNPTXenoport Inc | +0.28 | +4.33% |
| THLDThreshold Pharmaceut... | +0.27 | +5.09% |
| RPRXRepros Therapeutics ... | -0.32 | -1.88% |
| VICLVical Inc | +0.02 | +0.56% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$38.6M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Christopher M. Starr, PhD |
Chief Operating Officer & Executive VP-Strategy Julie Anne Smith |
Corporate headquarters Novato, California |
.
